Chemical Structure:
C10H16ClN2O
Mechanism of Action:
Edrophonium is a short-acting compound that reversibly binds to acetylcholinesterase. It differs from other cholinesterase inhibitors in its rapid onset and short duration of action, making it particularly useful for diagnostic purposes.
Uses:
It is used primarily for the diagnosis of myasthenia gravis and sometimes to differentiate between myasthenic crisis and cholinergic crisis.
Side Effects:
Because of its short action, side effects are less common but can include bradycardia, increased salivation, and muscle fasciculations.